Global Human Microbiome Market Report to 2029: Rising Awareness About Importance of Human Microbiome Drives Growth
June 06, 2023 09:53 ET
|
Research and Markets
Dublin, June 06, 2023 (GLOBE NEWSWIRE) -- The "Global Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics), Application (Therapeutic, Diagnostics), Disease (Cancer, Gastrointestinal,...
Global Peptide Therapeutics Market Report 2023: Sector is Expected to Reach $69.3 Billion by 2030 at a CAGR of 6.6%
May 25, 2023 12:33 ET
|
Research and Markets
Dublin, May 25, 2023 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics Market, By Product Type, By Application, By Route of Administration, and By Region - Size, Share, Outlook, and Opportunity...
$64.3 Billion Peptide Therapeutics Markets - Global Opportunity Analysis and Industry Forecasts, 2021-2022 & 2022-2031
March 23, 2023 12:53 ET
|
Research and Markets
Dublin, March 23, 2023 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics Market By Application, By Route of administration, By Distribution Channel: Global Opportunity Analysis and Industry Forecast,...
MBX Biosciences to Participate in the Oppenheimer 33rd Annual Healthcare Conference
March 07, 2023 08:00 ET
|
MBX Biosciences, Inc.
CARMEL, Ind., March 07, 2023 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision Endocrine Peptide™ (PEP™) therapeutics to treat an array of...
Human Microbiome Global Market Report 2022: Increasing Collaboration Between Public-Private Organizations Catalyzes Growth
December 29, 2022 05:53 ET
|
Research and Markets
Dublin, Dec. 29, 2022 (GLOBE NEWSWIRE) -- The "Human Microbiome Market Share, Size, Trends, Industry Analysis Report, By Product; By Application; By Disease, By Type; By Region; Segment Forecast,...
Global Peptide Therapeutics Market Report 2022 to 2028: Players Include AstraZeneca, Teva Pharmaceutical Industries, Novartis and Pfizer
November 24, 2022 08:03 ET
|
Research and Markets
Dublin, Nov. 24, 2022 (GLOBE NEWSWIRE) -- The "Global Peptide Therapeutics Market Size, Share & Industry Trends Analysis Report By Type (Innovative and Generic), By Route of Administration, By...
Global Human Microbiome Market Report 2022: Rising Focus on the Development of Therapeutics Driving Growth
November 02, 2022 06:03 ET
|
Research and Markets
Dublin, Nov. 02, 2022 (GLOBE NEWSWIRE) -- The "Global Human Microbiome Market Size, Share & Industry Trends Analysis Report By Product, By Disease Type, By Technology, By Application, By Type,...
Peptide Therapeutics Global Market Report 2022: Surging Rates of Chronic Disease Fueling Growth
October 18, 2022 08:18 ET
|
Research and Markets
Dublin, Oct. 18, 2022 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global peptide therapeutics market is...
Global Peptide Therapeutics Market Report 2022: Increasing Investments in Research and Development Activities of Novel Drugs & Technological Advancements in Peptide Therapeutics to Drive Growth
October 05, 2022 08:23 ET
|
Research and Markets
Dublin, Oct. 05, 2022 (GLOBE NEWSWIRE) -- The "Global Peptide Therapeutics Market Report and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.According to the report,...
L’étude sur le TH1902 de Theratechnologies publiée dans la revue Pharmaceutics montre une inhibition de la croissance des cellules de type souches cancéreuses humaines du cancer de l’ovaire et du CSTN exprimant le récepteur de la sortiline (SORT1) et de la croissance tumorale
September 12, 2022 07:30 ET
|
Theratechnologies
Les chercheurs signalent une activité anticancéreuse supérieure contre les cellules de type souches cancéreuses avec le TH1902, comparativement au docétaxel non conjugué.Premières données probantes...